Search

everythinglearnresearchcommunity

for

Search:↓

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Male yak hair growth is influenced by DHT synthesis, which is promoted by 5α-red1 and AR during growth phases, while E2 may inhibit growth through ERα.

PFOS exposure disrupts hormone levels and enzyme activities in juvenile frogs, affecting males and females differently.

The 2018 guideline for PCOS suggests new diagnostic criteria and treatments, but recognizes the need for more research.

Daily subcutaneous testosterone effectively restores testosterone levels in men.

The conclusion is that lifestyle changes and weight loss are first-line treatments for infertility due to anovulation, with various medications and assisted reproductive technologies as additional options.

A woman's hair loss and other symptoms were due to a rare hormone deficiency treatable with steroids.

Testosterone works in different ways, including direct interaction with its receptor, conversion to other hormones for specific effects on genitalia, hair, bones, and muscle, and changes in body fat and sexual function when low.

Androgens and estrogens are crucial for insulin secretion in males.

Finasteride and minoxidil are effective, low-risk treatments for male hair loss, and patient education on these therapies is important.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

PCOS requires personalized treatment to improve life quality and reduce health risks.

Polycystic ovary syndrome (PCOS) affects about 10% of women, is often linked to obesity and family history, and can cause irregular periods, fertility issues, and other symptoms. It's usually managed with lifestyle changes, weight loss, and medication.

Hair loss is a common side effect of hormone treatments for cancer.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Women with a certain type of hair loss have more copper in the back of their head than the front, and treatment can normalize hair but not copper levels.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

New treatments for male hypogonadism are easier to use and target specific tissues to reduce side effects.

ESR2 gene variations may be linked to female pattern hair loss.

Capsaicin cream quickly relieved itching in two patients with brachioradial pruritus.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

The study found that urine metabolites M1b or M4 are the best indicators of ATD use in horses, with detection possible up to 77 hours in urine and 28 hours in blood.

Hair can be used to measure cancer-related chemicals noninvasively.

Two gene variations, rs6493497 and rs7176005, may be linked to female hair loss in Chinese people.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.